| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/07/1993 | EP0549726A1 Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids |
| 07/07/1993 | EP0549723A1 Packaging cells |
| 07/07/1993 | EP0549711A1 Natural killer stimulatory factor |
| 07/07/1993 | EP0549691A1 Gene therapy for cystic fibrosis |
| 07/07/1993 | EP0549683A1 Dna fragments coding for a bacteriophage-resistant mecanism |
| 07/07/1993 | EP0549673A1 Viral growth inhibition |
| 07/07/1993 | EP0549662A1 Plasmodium liver stage antigens |
| 07/07/1993 | EP0542934A4 Method of treating benign and malignant proliferative skin disease |
| 07/07/1993 | EP0380554B1 Vasoactive peptides |
| 07/07/1993 | CN1073980A Collagen-like polypertides |
| 07/07/1993 | CN1073979A A87689 compounds |
| 07/07/1993 | CN1073978A Novel synthetic isohirudins with improved stability |
| 07/07/1993 | CN1073977A Recombinant gene coding for human alpha interferon and expression vector thereof, ETC. |
| 07/07/1993 | CN1073976A Tissue-selective insulin anaiogs |
| 07/07/1993 | CN1073878A Expression of specific immunogens using viral antigens |
| 07/06/1993 | US5225546 Probe/primer of purified single strand oligonucleotides, gene encoding |
| 07/06/1993 | US5225543 Receptors method for purification of g protein-linked |
| 07/06/1993 | US5225538 Diagnostic, theraputic |
| 07/06/1993 | US5225537 Methods for producing hybrid phospholipid-binding proteins |
| 07/06/1993 | US5225535 Lymphokine SAF and method of making |
| 07/06/1993 | US5225534 Immunology for malaria |
| 07/06/1993 | US5225531 Hexapeptide Lys Gly Ala Gly Asp Val |
| 07/06/1993 | US5225530 Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections |
| 07/06/1993 | US5225529 Synthetic amphiphilic glycoconjugates for neurological use |
| 07/06/1993 | US5225400 Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/1993 | US5225354 Binding glycosylated lysine in albumin to monoclonal antibodies |
| 07/06/1993 | US5225348 DNA fragment and expression plasmid containing the DNA fragment |
| 07/06/1993 | US5225347 Therapeutic ribozyme compositions and expression vectors |
| 07/06/1993 | US5225337 Ribozyme compositions and methods for use |
| 07/06/1993 | US5225336 Recombinant poxvirus host range selection system |
| 07/06/1993 | US5225331 Immunoassay for detecting group b streptococcus |
| 07/06/1993 | US5225324 Diagnostics for mycobacteria in public health, medical, and veterinary practice |
| 07/06/1993 | US5225323 Human high-affinity neurotransmitter uptake system |
| 07/06/1993 | US5225193 Bordetella toxin peptides and vaccines |
| 07/06/1993 | US5225182 For specific organ delivery |
| 07/06/1993 | CA1319850C Mehod for inhibiting listeria monocytogenes using a bacteriocin |
| 07/01/1993 | DE4244418A1 Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc. |
| 07/01/1993 | CA2086362A1 Sex specific promoter |
| 07/01/1993 | CA2058598A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines |
| 06/30/1993 | EP0549066A1 Serpulina hyodysenteriae vaccine |
| 06/30/1993 | EP0549062A2 A eukaryotic expression system |
| 06/30/1993 | EP0548867A2 Soluble stem cell factor (SFC)-receptor |
| 06/30/1993 | EP0548557A1 Construct and method for expression of heterologous genes in E.coli |
| 06/30/1993 | EP0548441A1 Endothelin antagonists |
| 06/30/1993 | EP0548267A1 Production of insulin-like growth factor-1 in methylotrophic yeast cells |
| 06/30/1993 | EP0548252A1 Genetically engineered coccidiosis vaccine |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
| 06/30/1993 | EP0548214A1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS |
| 06/30/1993 | EP0548200A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 06/30/1993 | EP0548197A1 Plant parasitic nematode control |
| 06/30/1993 | EP0548190A1 Novel antibodies for treatment and prevention of infection in animals and man |
| 06/30/1993 | EP0548165A1 Expression of g protein coupled receptors in yeast |
| 06/30/1993 | EP0548138A1 Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof |
| 06/30/1993 | EP0548123A1 Anti-inflammatory factor, method of isolation, and use |
| 06/30/1993 | EP0522073A4 Improved major histocompatibility complex (mhc) molecules |
| 06/30/1993 | EP0441939A4 Wound healing |
| 06/30/1993 | CN1073719A Nanbv diagnostics and vaccines |
| 06/30/1993 | CN1073717A Insecticidal protein-encoding gene, gramineous plants transformed with the gene, and production thereof |
| 06/30/1993 | CN1073684A Polypeptide analogues having growth hormone releasing activity |
| 06/30/1993 | CN1073604A Process for preparing higher immunogenic hepatitis B vaccine |
| 06/29/1993 | WO1993008282A1 New thrombin-inhibiting protein isolated from ticks |
| 06/29/1993 | US5223611 DNA encoding for human GP130 protein |
| 06/29/1993 | US5223610 Cholera toxin gene regulated by growth hormone promoter |
| 06/29/1993 | US5223606 Steroid/thyroid hormone receptor-related protein inappropriately expressed in human hepatocellular carcinoma |
| 06/29/1993 | US5223605 Interleukin-4 binding protein-γ |
| 06/29/1993 | US5223604 For inhibiting binding of pseudomonas bacteria to epithelial cells or for vaccines to immunize against them |
| 06/29/1993 | US5223485 Anaphylatoxin-receptor ligands |
| 06/29/1993 | US5223484 Dodecapeptide containing cysteine, histidine, arginine, lysine, glycine, tyrosine, alanine, aspartic acid, leucine |
| 06/29/1993 | US5223483 Cysteine-modified acidic fibroblast growth factor |
| 06/29/1993 | US5223482 Polypeptide |
| 06/29/1993 | US5223481 Biologically active lipoprotein and its use |
| 06/29/1993 | US5223441 Receptors for immune complexes |
| 06/29/1993 | US5223427 Synthetic polypeptide |
| 06/29/1993 | US5223426 Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| 06/29/1993 | US5223425 DNA sequence which codes serine protease for diagnosis and/or treatment of obesity or metabolic defects |
| 06/29/1993 | US5223424 Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence |
| 06/29/1993 | US5223423 Characterization of replication competent human immunodeficiency type 2 proviral clone hiv-2sbl/isy |
| 06/29/1993 | US5223422 T-pa mutant gk1l |
| 06/29/1993 | US5223419 Alteration of gene expression in plants |
| 06/29/1993 | US5223418 Using casamino acid |
| 06/29/1993 | US5223417 Infecting with epstein-barr virus, transforming with activated ras gene |
| 06/29/1993 | US5223412 Culturing of microorganism; controlling temperature |
| 06/29/1993 | US5223409 Directed evolution of novel binding proteins |
| 06/29/1993 | US5223408 Method for making variant secreted proteins with altered properties |
| 06/29/1993 | US5223407 Culturing genetically transformed E. coli strains |
| 06/29/1993 | US5223394 Recombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequence |
| 06/29/1993 | US5223391 Inhibitors of herpes simplex virus replication |
| 06/29/1993 | US5223256 Thrombolytically active non-glycosylated protein |
| 06/29/1993 | US5223255 Bordetella pertussis variants |
| 06/29/1993 | US5223254 Polypeptide |
| 06/29/1993 | CA2121134A1 Novel thrombin-inhibitory protein from ticks |
| 06/29/1993 | CA1319631C Method for the production of proteins by means of inducible expression systems in genetically modified eukaryotic host-cells multiplicated in-vivo |
| 06/29/1993 | CA1319629C Fusion proteins |
| 06/29/1993 | CA1319628C Fusion proteins |
| 06/29/1993 | CA1319611C Purified hemoglobin solutions and method for making same |
| 06/28/1993 | CA2086162A1 Oligonucleotides, oligopeptides and determination system of hcv antibody subtype |
| 06/28/1993 | CA2086079A1 Peptide, production and use thereof |
| 06/25/1993 | CA2086142A1 Prolyl endopeptidase inhibitor |
| 06/24/1993 | WO1994012205A1 Dynorphin a suppression of natural killer cell activity |
| 06/24/1993 | WO1993012251A1 Senescent cell derived inhibitors of dna synthesis |